Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus
Combating tuberculosis requires new therapeutic strategies that not only target the actively
dividing bacilli but also the dormant bacilli during persistent infection. Isocitrate lyase (ICL) is
a key enzyme of the glyoxylate shunt, crucial for the survival of bacteria in macrophages and
mice. MtbICL is considered as one of the potential and attractive drug targets against
persistent infection. We report the inhibition of MtbICL by quercetin with IC 50 of 3.57 μM. In
addition, quercetin strongly inhibited the growth of Mtb H37Rv utilizing acetate, rather than …
dividing bacilli but also the dormant bacilli during persistent infection. Isocitrate lyase (ICL) is
a key enzyme of the glyoxylate shunt, crucial for the survival of bacteria in macrophages and
mice. MtbICL is considered as one of the potential and attractive drug targets against
persistent infection. We report the inhibition of MtbICL by quercetin with IC 50 of 3.57 μM. In
addition, quercetin strongly inhibited the growth of Mtb H37Rv utilizing acetate, rather than …
Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.
HS Harish Shukla, VK Vikash Kumar, AK Singh… - 2015 - cabidigitallibrary.org
Combating tuberculosis requires new therapeutic strategies that not only target the actively
dividing bacilli but also the dormant bacilli during persistent infection. Isocitrate lyase (ICL) is
a key enzyme of the glyoxylate shunt, crucial for the survival of bacteria in macrophages and
mice. MtbICL is considered as one of the potential and attractive drug targets against
persistent infection. We report the inhibition of MtbICL by quercetin with IC50 of 3.57 µM. In
addition, quercetin strongly inhibited the growth of Mtb H37Rv utilizing acetate, rather than …
dividing bacilli but also the dormant bacilli during persistent infection. Isocitrate lyase (ICL) is
a key enzyme of the glyoxylate shunt, crucial for the survival of bacteria in macrophages and
mice. MtbICL is considered as one of the potential and attractive drug targets against
persistent infection. We report the inhibition of MtbICL by quercetin with IC50 of 3.57 µM. In
addition, quercetin strongly inhibited the growth of Mtb H37Rv utilizing acetate, rather than …
以上显示的是最相近的搜索结果。 查看全部搜索结果